Brokerages expect that Cardinal Health (NYSE:CAH) will announce earnings per share (EPS) of $1.51 for the current quarter, according to Zacks. Eight analysts have made estimates for Cardinal Health’s earnings, with the highest EPS estimate coming in at $1.57 and the lowest estimate coming in at $1.45. Cardinal Health reported earnings of $1.53 per share in the same quarter last year, which suggests a negative year over year growth rate of 1.3%. The business is scheduled to report its next quarterly earnings report before the market opens on Thursday, May 3rd.

According to Zacks, analysts expect that Cardinal Health will report full-year earnings of $5.42 per share for the current financial year, with EPS estimates ranging from $5.34 to $5.60. For the next fiscal year, analysts anticipate that the firm will report earnings of $6.12 per share, with EPS estimates ranging from $6.00 to $6.26. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side analysts that follow Cardinal Health.

How to Become a New Pot Stock Millionaire

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 8th. The company reported $1.31 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.14 by $0.17. The firm had revenue of $35.19 billion for the quarter, compared to analysts’ expectations of $34.63 billion. Cardinal Health had a net margin of 1.37% and a return on equity of 24.81%. The firm’s revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.34 earnings per share.

Several brokerages recently weighed in on CAH. Zacks Investment Research raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $84.00 target price on the stock in a report on Monday, January 29th. Mizuho set a $73.00 target price on shares of Cardinal Health and gave the company a “hold” rating in a report on Wednesday, January 24th. Robert W. Baird reaffirmed a “hold” rating and issued a $80.00 target price on shares of Cardinal Health in a report on Wednesday, January 17th. TheStreet raised shares of Cardinal Health from a “c+” rating to a “b-” rating in a report on Tuesday, March 13th. Finally, Bank of America began coverage on shares of Cardinal Health in a report on Tuesday, February 27th. They issued an “underperform” rating and a $69.00 target price on the stock. Three equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $74.13.

Shares of NYSE:CAH opened at $62.29 on Friday. The company has a market capitalization of $19,014.59, a P/E ratio of 11.53, a PEG ratio of 1.38 and a beta of 1.07. Cardinal Health has a fifty-two week low of $54.66 and a fifty-two week high of $81.91. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.57 and a current ratio of 1.09.

Cardinal Health announced that its board has authorized a share repurchase program on Thursday, February 8th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which was paid on Sunday, April 15th. Shareholders of record on Monday, April 2nd were issued a dividend of $0.4624 per share. The ex-dividend date was Thursday, March 29th. This represents a $1.85 dividend on an annualized basis and a yield of 2.97%. Cardinal Health’s payout ratio is currently 34.26%.

In other news, CEO Jon L. Giacomin sold 7,995 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $68.78, for a total transaction of $549,896.10. Following the transaction, the chief executive officer now directly owns 63,043 shares in the company, valued at $4,336,097.54. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Patricia Morrison sold 28,532 shares of the firm’s stock in a transaction that occurred on Wednesday, February 14th. The stock was sold at an average price of $66.30, for a total transaction of $1,891,671.60. Following the transaction, the insider now owns 36,157 shares in the company, valued at $2,397,209.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 55,113 shares of company stock worth $3,815,073. 0.97% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Janus Henderson Group PLC grew its position in shares of Cardinal Health by 77.8% during the third quarter. Janus Henderson Group PLC now owns 108,930 shares of the company’s stock worth $7,291,000 after acquiring an additional 47,669 shares during the last quarter. New Mexico Educational Retirement Board grew its position in shares of Cardinal Health by 3.7% during the fourth quarter. New Mexico Educational Retirement Board now owns 30,454 shares of the company’s stock worth $1,866,000 after acquiring an additional 1,100 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of Cardinal Health by 28.7% during the fourth quarter. Wells Fargo & Company MN now owns 1,318,252 shares of the company’s stock worth $80,768,000 after acquiring an additional 293,863 shares during the last quarter. Toronto Dominion Bank grew its position in shares of Cardinal Health by 13.0% during the fourth quarter. Toronto Dominion Bank now owns 135,627 shares of the company’s stock worth $8,310,000 after acquiring an additional 15,613 shares during the last quarter. Finally, Stone Ridge Asset Management LLC purchased a new position in shares of Cardinal Health during the fourth quarter worth approximately $354,000. Institutional investors and hedge funds own 90.02% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Analysts Expect Cardinal Health (CAH) to Post $1.51 Earnings Per Share” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2018/04/17/analysts-expect-cardinal-health-cah-to-post-1-51-earnings-per-share.html.

Cardinal Health Company Profile

Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.